Colgate-Palmolive Company (CL) EPS Estimated At $0.75

January 15, 2018 - By Michael Collier

 Colgate Palmolive Company (CL) EPS Estimated At $0.75
Investors sentiment is 0.9 in 2017 Q3. Its the same as in 2017Q2. It has no change, as 52 investors sold Colgate-Palmolive Company shares while 437 reduced holdings. only 92 funds opened positions while 350 raised stakes. 617.24 million shares or 0.04% less from 617.46 million shares in 2017Q2 were reported.
Strs Ohio holds 0.15% of its portfolio in Colgate-Palmolive Company (NYSE:CL) for 477,784 shares. Mariner Wealth Advsrs Ltd Llc reported 22,143 shares. Pittenger & Anderson reported 28,939 shares. First Midwest Bankshares Trust Division holds 0.12% in Colgate-Palmolive Company (NYSE:CL) or 13,491 shares. Checchi Capital Advisers Limited Liability holds 0.05% of its portfolio in Colgate-Palmolive Company (NYSE:CL) for 6,783 shares. 188,616 are held by Nordea Investment. Moreover, Becker Capital Management has 0.01% invested in Colgate-Palmolive Company (NYSE:CL). Franklin Resources has invested 0.17% in Colgate-Palmolive Company (NYSE:CL). Citigroup Incorporated reported 791,491 shares stake. 68,957 are held by First Personal Financial. Pinebridge Limited Partnership holds 0.03% or 15,191 shares. 3,050 were reported by Train Babcock Ltd Liability Com. Advisory Ntwk Ltd Liability Company accumulated 30,296 shares. Boys Arnold accumulated 15,518 shares or 0.18% of the stock. Noesis Mangement Corp stated it has 0.13% in Colgate-Palmolive Company (NYSE:CL).

Since August 1, 2017, it had 0 insider purchases, and 7 sales for $10.99 million activity. The insider MOISON FRANCK J sold $2.50M. Another trade for 73,872 shares valued at $5.30M was sold by HICKEY DENNIS J. Shares for $1.00M were sold by Marsili Daniel B on Tuesday, August 15. Daniels Jennifer had sold 7,375 shares worth $539,694 on Wednesday, December 13. HUSTON JOHN J had sold 14,000 shares worth $999,064 on Thursday, August 10. HANCOCK ELLEN M had sold 5,057 shares worth $363,664 on Tuesday, August 1.

Analysts expect Colgate-Palmolive Company (NYSE:CL) to report $0.75 EPS on January, 26.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $0.75 EPS. CL’s profit would be $658.58M giving it 24.87 P/E if the $0.75 EPS is correct. After having $0.73 EPS previously, Colgate-Palmolive Company’s analysts see 2.74 % EPS growth. The stock increased 0.09% or $0.07 during the last trading session, reaching $74.62. About 2.34 million shares traded. Colgate-Palmolive Company (NYSE:CL) has risen 6.23% since January 15, 2017 and is uptrending. It has underperformed by 10.47% the S&P500.

Colgate-Palmolive Company (NYSE:CL) Ratings Coverage

Among 25 analysts covering Colgate-Palmolive (NYSE:CL), 6 have Buy rating, 1 Sell and 18 Hold. Therefore 24% are positive. Colgate-Palmolive had 63 analyst reports since July 21, 2015 according to SRatingsIntel. BNP Paribas upgraded Colgate-Palmolive Company (NYSE:CL) on Monday, January 18 to “Outperform” rating. As per Monday, November 2, the company rating was maintained by Deutsche Bank. The firm has “Hold” rating given on Monday, September 18 by Stifel Nicolaus. Citigroup maintained Colgate-Palmolive Company (NYSE:CL) rating on Thursday, November 2. Citigroup has “Neutral” rating and $75 target. The company was maintained on Tuesday, September 5 by RBC Capital Markets. The stock has “Equal-Weight” rating by Barclays Capital on Monday, March 21. On Friday, September 4 the stock rating was upgraded by Zacks to “Hold”. On Monday, January 30 the stock rating was downgraded by Citigroup to “Neutral”. The rating was maintained by KeyBanc Capital Markets on Wednesday, November 22 with “Hold”. Jefferies maintained Colgate-Palmolive Company (NYSE:CL) on Friday, July 21 with “Hold” rating.

Colgate-Palmolive Company, together with its subsidiaries, makes and sells consumer products worldwide. The company has market cap of $65.52 billion. It operates through two divisions, Oral, Personal and Home Care; and Pet Nutrition. It has a 28.81 P/E ratio. The firm offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, and other related products.

More notable recent Colgate-Palmolive Company (NYSE:CL) news were published by: which released: “Colgate-Palmolive a Slow But Steady ‘Dividend Aristocrat'” on December 30, 2017, also with their article: “Norwest Venture Partners Portfolio Company PCA SKIN® Acquired by Colgate …” published on January 04, 2018, published: “UPDATE: Macquarie Upgrades Colgate-Palmolive Company (CL) to Outperform” on December 19, 2017. More interesting news about Colgate-Palmolive Company (NYSE:CL) were released by: and their article: “Colgate-Palmolive Enters Professional Skincare Market With Key Acquisitions …” published on December 18, 2017 as well as‘s news article titled: “Colgate Palmolive: No Growth, High Price” with publication date: January 08, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.